GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BioAdaptives BDPT · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

-12.94%

Close of 5 Nov 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$18,278

FY2016FY2025

Net income

−$1.6m

FY2016FY2025

Free cash flow

−$534,025

FY2016FY2025

Shareholders' equity

−$2.1m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$18,278$12,669$28,565$17,176$19,776$16,327$9,934——$19,044
Operating income−$1.0m−$602,000−$229,000−$422,000−$636,000−$254,326−$234,407−$657,941−$64,420−$171,348
Net income−$1.6m−$899,000−$712,000−$896,000−$1.1m−$1.1m−$438,246−$1.4m−$62,499−$171,348
Diluted earnings per share-0.13-0.11-0.12-0.70-3.95-7.81-0.02-11.56-0.64-1.81

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$225,901$261,885$103,998$37,314$148,585$18,846$24,213$110,059$3,563$146,557
Cash and short-term investments$158,445$137,470$60,776$25,447$83,126$5,031$13,085$60,202$3,563$11,283
Total liabilities$2.4m$1.7m$1.8m$1.5m$1.2m$1.4m$864,089$803,800$58$322,917
Debt$384,428$343,096$329,178$392,039$436,832$482,951$370,111$87,811——
Shareholders' equity−$2.1m−$1.5m−$1.6m−$1.5m−$1.1m−$1.4m−$839,876−$693,741$3,505−$176,360
Shares outstanding12m8m6m1m0m0m19m0m0m0m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−$516,025−$249,517−$223,773−$227,259−$158,651−$106,889−$168,120−$402,145−$540$5,573
Capital spending−$18,000−$3−$3———————
Free cash flow−$534,025−$249,520−$223,776−$227,259−$158,651−$106,889−$168,120−$402,145−$540$5,573

Growth per year

Compound annual rate

3 years5 years10 years
Revenue2.1%2.3%—
Operating income35.2%32.6%16.4%
Net income20.2%7.7%21.2%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-5312.9%-2992.9%-2824.2%—
Net margin-7939.1%-5300.6%-5490.2%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2021FY2019
Price to earnings-0.0———-0.0
Price to sales0.70.10.00.00.5

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return516%136%98%-95%88%90%440%1265%16%15262%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 300-to-1 reverse split · 21 Nov 2024

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.